XenaCare merging with Sun Packing
This article was originally published in The Tan Sheet
Executive SummaryDelray Beach, Fla.-based nutritional product firm XenaCare Holdings, which is launching the SunPill supplement designed to help protect skin, announced Aug. 22 it filed with the Securities and Exchange Commission to merge with Houston -based Sun Packing. Through the deal expected to close by October, XenaCare says it will put Sun Packing in charge of 50.1 percent of shares in the merged company. The merger "will reflect a combined business entity with expected first year sales in excess of $15 million and the capability" to apply for NASDAQ or American Stock Exchange Listing, says XenaCare President Frank Rizzo. XenaCare says a new name reflecting both businesses may be developed
You may also be interested in...
CDER Office of New Drugs changes its organization including establishing Office of Nonprescription Drugs and splitting the office into Division of Nonprescription Drug Products I and DNDP II. A Division of Regulatory Operations for Nonprescription Drugs will be comprised of regulatory staff from the ONPD divisions and will report to OND’s regulatory office. Non-clinical ONPD staff will report to the office director.
Anticipating a July approval of its cantharidin formulation, Verrica says it is poised to implement a buy-and-bill model for a clinician-administered product with an addressable market of 6 million.
Medicaid programs are essentially getting Humira for free, in large part because of price inflation rebates, according to estimates by Bernstein analysts. Legislation pending in the US Senate wants to bring that dynamic to Medicare.